Piper Sandler's IBD SmartSelect Composite Rating increased to 96, indicating it outperforms 96% of stocks in key metrics. The company reported a 17% earnings gain in Q2, with top-line growth rising 17% year-over-year. The stock is currently in consolidation with a 351.80 entry price, and institutional buying is indicated by its Accumulation/Distribution Rating of B. Other top-rated stocks in the Finance-Investment Banking/Brokers industry include Futu Holdings ADR, Robinhood Markets, and Interactive Brokers.

The article compares Futu Holdings Limited Sponsored ADR (FUTU) and SPX Technologies (SPXC) in the Technology Services sector, analyzing their valuation metrics and Zacks Rank to determine which stock offers better value.

The article discusses U.S. stock market volatility due to stalled trade talks with China and the Federal Reserve's interest rate decision. It recommends low-beta stocks like VIPS, GDS, FUTU, and VRNA for portfolio resilience, explaining beta metrics and screening criteria for selecting these stocks.

The article discusses U.S. stock market volatility due to stalled trade talks with China and the Federal Reserve's interest rate decision. It recommends low-beta stocks like VIPS, GDS, FUTU, and VRNA as a strategy to navigate uncertainty, explaining beta metrics and screening criteria for portfolio selection.

Stifel Financial achieved a Relative Strength (RS) Rating of 82, surpassing the 80-plus percentile, indicating strong market leadership. The stock is in a buy zone above 110.90, with a 5% target range. The company reported -67% earnings growth and 4% sales increase in the latest quarter, with the next report expected on July 30. It ranks No. 19 among peers in the Finance-Investment Banking/Brokers industry.